The combined detection of VEGF and CLR levels at the end of radiotherapy can evaluate clinical response, which is believed to be related to the inhibition of tumor by acute inflammation caused by radiotherapy and oxidative stress20. The gene discussed is VEGFA; the disease is neoplasm.